Markets:

Overview

News

Currencies

International

Treasuries

The Carlyle Group Inc. - Common Stock (NQ:CG)

35.62 -1.62 (-4.36%)

Delayed Quote Updated: 11:31 AM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about The Carlyle Group Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Oppenheimer Analysts Slash Estimates For Goldman Sachs, Jefferies Amid Subdued M&A Activity ↗

March 19, 2025

Analysts expect rebound in M&A and financing activity, but uncertainties may pause it. Estimates slashed for GS and JEF, CG downgraded to Perform.

Via Benzinga

Tariffs Tangle Markets, Businesses, Investors ↗

March 12, 2025

When uncertainty spikes, our ability to look out into the future shrinks.

Via The Motley Fool

Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal ↗

March 11, 2025

Bristol Myers Squibb to acquire 2seventy Bio for $5.00 per share in a $286 million all-cash deal, an 88% premium to its last close. Expected to close in Q2 2025.

Via Benzinga

What's Going On With Gene Therapy Company Bluebird Bio Stock Today? ↗

February 21, 2025

bluebird bio agrees to be acquired by Carlyle Group and SK Capital, offering stockholders up to $9.84 per share in a strategic buyout.

Via Benzinga

What's Driving the Market Sentiment Around Carlyle Group? ↗

February 21, 2025

Via Benzinga

Earnings Scheduled For February 20, 2025 ↗

February 20, 2025

Via Benzinga

The Analyst Verdict: Carlyle Group In The Eyes Of 6 Experts ↗

February 12, 2025

Via Benzinga

The Analyst Verdict: Carlyle Group In The Eyes Of 14 Experts ↗

January 03, 2025

Via Benzinga

The Analyst Verdict: Carlyle Group In The Eyes Of 14 Experts ↗

December 12, 2024

Via Benzinga

bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital

February 21, 2025

From bluebird bio, Inc.

Via Business Wire

US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday? ↗

February 11, 2025

U.S.

Via Benzinga

Advance Auto Parts Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗

November 14, 2024

Via Benzinga

Analyst Scoreboard: 12 Ratings For Carlyle Group ↗

November 08, 2024

Via Benzinga

Carlyle Group Stock Slips After Q4 Profit Miss: Retail Remains Neutral ↗

February 11, 2025

The company’s fee-earning assets under management (AUM) fell by 1% to $304 billion compared with last year.

Via Stocktwits

Acentra Health Welcomes Distinguished Public Sector Health Leaders Calder Lynch and Jami Snyder to its Healthcare Advisory Board; Appoints Julie Boughn as New Chair

February 04, 2025

Industry experts join board of seasoned advisors offering strategic counsel on healthcare trends and policy for the company and its portfolio of state, federal, and commercial clients

From Acentra Health

Via GlobeNewswire

Baxter Kidney Care is Now Vantive, A New Standalone Vital Organ Therapy Company

February 03, 2025

From Vantive

Via GlobeNewswire

A Closer Look at 17 Analyst Recommendations For Carlyle Group ↗

October 23, 2024

Via Benzinga

Acentra Health Appoints Ezmeralda Sager as Chief Transformation Officer

January 23, 2025

Industry changemaker to drive transformation and operational improvements in the development and delivery of the company’s healthcare products, solutions, and services

From Acentra Health

Via GlobeNewswire

Copia Power and Arizona Public Service (APS) Enter Into 20-Year Power Purchase Agreements for Large-Scale Solar and Storage Energy Campus

January 17, 2025

Via ACCESS Newswire

2025 Industry Shake-Up: Goldman Highlights KKR, Raymond James, Hamilton Lane ↗

January 06, 2025

Goldman Sachs predicts winners and losers among alternative asset managers, brokers, and traditional managers in 2025, with bold rating adjustments.

Via Benzinga

Bank Of America Raises Bullish Outlook On US Brokers, Exchanges, Alternative Investments: 3 Top Picks For 2025 ↗

December 11, 2024

Bank of America bullish on U.S. brokers, asset managers and exchanges for 2025. Red wave in 2024 to open doors for crypto and alts. Blue Owl, IBKR and TW top picks; HOOD and SCHW underperformers.

Via Benzinga

TeamViewer Agrees To Acquire Carlyle-Backed 1E For $720 Million: Details ↗

December 11, 2024

TeamViewer to acquire 1E for $720 million, boosting IT performance and employee satisfaction. Deal expected to close in early 2025.

Via Benzinga

Acentra Health’s Independent Medical Review Division Earns Accreditation from Leading Care Quality and Safety Organization

December 05, 2024

Consecutive accreditations from URAC spanning 24 years underscore the company’s unwavering compliance with rigorous standards for independent medical reviews

From Acentra Health

Via GlobeNewswire

These 3 Stocks Are Heavy Hitters in Alternative Asset Management

November 30, 2024

These three companies are known for their expertise in alternative and private asset management, an industry with attractive characteristics.

Via MarketBeat

Baxter International: Dividend Cut Because Of Restructuring ↗

November 29, 2024

Baxter International (BAX) cut its dividend because of the upcoming sale of the Kidney Care business, high debt and leverage, lower earnings per share, and free cash flow.

Via Talk Markets

Topics Stocks / Equities

Rubber Meets Road For Divergent Buyout-Shop Models ↗

November 11, 2024

The share prices for the private equity and credit foursome, with nearly $3 trillion of combined assets under management, jumped immediately following the election.

Via Talk Markets

9 Stocks To Watch: Financial Sector Outshines Tech In 2024 As 'Trump Trade' Sparks M&A Optimism ↗

November 07, 2024

The Financial Select Sector SPDR Fund has surged 30% this year, outpacing the Technology Select Sector SPDR Fund.

Via Benzinga

Trump Trade Sparks Biggest Financial Stock Inflows In 2 Years ↗

November 11, 2024

Financial stocks rally after Trump's return to White House; investors expect deregulation and tax cuts. Goldman Sachs predicts top picks in sector.

Via Benzinga

Topics Government

Carlyle Group's Mixed Q3: Record Q3 Fee-Related Earnings, Revenue Miss & More ↗

November 07, 2024

Carlyle Group (CG) reported Q3 FY24 earnings of $0.95 per share, beating consensus of $0.90. Revenues of $895.0 million missed consensus of $921.7 million.

Via Benzinga

Weekly Commentary: Accelerating Wall Street and Subprime Booms ↗

October 20, 2024

Is it legitimate (in this day and age) to fret about a downturn and weakening labor markets with Wall Street absolutely booming?

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

The Carlyle Group Inc. - Common Stock (NQ:CG)

All News about The Carlyle Group Inc. - Common Stock

Starting at /week.